Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats

American Journal of Physiology - Renal Physiology

Volumn 310, Issue 9, 2016, Pages F857-F871

  Kieffer, Dorothy A ^a,b   Piccolo, Brian D ^d   Vaziri, Nosratola D ^c   Liu, Shuman ^c   Lau, Wei L ^c   Khazaeli, Mahyar ^c   Nazertehrani, Sohrab ^c   Moore, Mary E ^b   Marco, Maria L ^b   Martin, Roy J ^a   Adams, Sean H ^b,d  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Chronic kidney disease; Dietary fiber; Gut microbiota; Resistant starch; Uremic retention solutes

Indexed keywords

5 METHOXYTRYPTAMINE; ACETIC ACID DERIVATIVE; AMYLOSE; ASPARTIC ACID; CREATININE; ETHANOLAMINE; GLYCYLPROLINE; HYDROXYLAMINE; HYDROXYPROLINE; ISOLEUCINE; LACTIC ACID; LEUCINE; LYSINE; MALEIMIDE; METHIONINE; METHIONINE SULFOXIDE; N ACETYLGLUTAMIC ACID; NICOTINIC ACID; PHENYLALANINE; PHOSPHOETHANOLAMINE; PYRIDOXIC ACID; RESISTANT STARCH; SERINE; STARCH; TIGHT JUNCTION PROTEIN; UNCLASSIFIED DRUG; URACIL; UREA; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE; VALINE; XANTHINE; 4-CRESOL; CRESOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEROIDETES; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE CLEARANCE; DIETARY FIBER; HUMAN; INTESTINE FLORA; KIDNEY FUNCTION; MAIZE; MALE; METABOLOMICS; MICROBIAL DIVERSITY; MICROBIAL METABOLISM; MICROBIOME; NONHUMAN; PRIORITY JOURNAL; PROTEOBACTERIA; RAT; RUMINOCOCCUS; SUTTERELLA; ANIMAL; CECUM; CHRONIC KIDNEY FAILURE; DIET; DRUG EFFECTS; KIDNEY FUNCTION TEST; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; PH; PHARMACOLOGY; SPRAGUE DAWLEY RAT; UREMIA; URINE;

ANIMALS; CECUM; CRESOLS; DIET; DIETARY FIBER; GASTROINTESTINAL MICROBIOME; HYDROGEN-ION CONCENTRATION; KIDNEY FUNCTION TESTS; MALE; METABOLOMICS; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY, CHRONIC; STARCH; UREMIA;

EID: 84984616719     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00513.2015     Document Type: Article

References (87)

1. Annison G, Topping DL. Nutritional role of resistant starch: chemical structure vs physiological function. Annu Rev Nutr 14: 297–320, 1994.
2. Baker D. Determing fiber in cereals. Cereal Chem 54: 360–365, 1977.
3. Bansal T, Alaniz RC, Wood TK, Jayaraman A. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc Natl Acad Sci USA 107: 228–233, 2010.
4. Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, Choukroun G, Vanholder R, Massy ZA. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 4: 1551–1558, 2009.
5. Belobrajdic DP, King RA, Christophersen CT, Bird AR. Dietary resistant starch dose-dependently reduces adiposity in obesity-prone and obesity-resistant male rats. Nutr Metab 9: 93–93, 2012.
6. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Series B 57: 289–300, 1995.
7. Bourke E, Milne MD, Stokes GS. Caecal pH and ammonia in experimental uraemia. Gut 7: 558–561, 1966.
8. Campbell C, Grapov D, Fiehn O, Chandler CJ, Burnett DJ, Souza EC, Casazza GA, Gustafson MB, Keim NL, Newman JW. Improved metabolic health alters host metabolism in parallel with changes in systemic xeno-metabolites of gut origin. PLos One 9: e84260, 2014.
9. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7: 335–336, 2010.
10. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, Fierer N, Knight R. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci USA 108, Suppl 1: 4516–4522, 2011.
11. Cueva C, Moreno-Arribas MV, Martín-Álvarez PJ, Bills G, Vicente MF, Basilio A, Rivas CL, Requena T, Rodríguez JM, Bartolomé B. Antimicrobial activity of phenolic acids against commensal, probiotic and pathogenic bacteria. Res Microbiol 161: 372–382, 2010.
12. Cummings J, Hill M, Bone E, Branch W, Jenkins D. The effect of meat protein and dietary fiber on colonic function and metabolism. II. Bacterial metabolites in feces and urine. Am J Clin Nutr 32: 2094–2101, 1979.
13. Cummings JH. Fermentation in the human large intestine: evidence and implications for health. Lancet 1: 1206–1209, 1983.
14. De Schrijver R, Vanhoof K, Vande Ginste J. Nutrient utilization in rats and pigs fed enzyme resistant starch. Nutr Res 19: 1349–1361.
15. Earle KA, Billings G, Sigal M, Lichtman JS, Hansson GC, Elias JE, Amieva MR, Huang KC, Sonnenburg JL. Quantitative imaging of gut microbiota spatial organization. Cell Host Microbe 18: 478–488.
16. Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Neyrinck AM, Possemiers S, Van Holle A, François P, de Vos WM, Delzenne NM, Schrenzel J, Cani PD. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and dietinduced leptin-resistant mice. Diabetes 60: 2775–2786, 2011.
17. Fiehn O, Kind T. Metabolite profiling in blood plasma. Methods Mol Biol 358: 3–17, 2007.
18. Fiehn O, Wohlgemuth G, Scholz M. Setup and annotation of metabolomic experiments by integrating biological and mass spectrometric metadata. In: Data Integration in the Life Sciences, edited by Ludäscher B, Raschid L. Berlin: Springer, 2005, p. 224–239.
19. Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 9: 577–589, 2012.
20. Fuentes-Zaragoza E, Riquelme-Navarrete MJ, Sánchez-Zapata E, Pérez-Álvarez JA. Resistant starch as functional ingredient: a review. Food Res Int 43: 931–942, 2010.
21. Geurts L, Neyrinck AM, Delzenne NM, Knauf C, Cani PD. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Beneficial Microbes 5: 3–17, 2014.
22. Gibson GR. Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 80: S209–S212, 1998.
23. Gilbert RM, Weber H, Turchin L, Fine LG, Bourgoignie JJ, Bricker NS. A study of the intrarenal recycling of urea in the rat with chronic experimental pyelonephritis. J Clin Invest 58: 1348–1357, 1976.
24. Grabitske HA, Slavin JL. Gastrointestinal effects of low-digestible carbohydrates. Crit Rev Food Sci Nutr 49: 327–360, 2009.
25. Hastie T, Tibshirani R, Narasimhan B, Chu G. impute: Imputation for Microarray Data (online). http://rpackages.ianhowson.com/bioc/impute/ [17 August 2015].
26. Hatch M, Freel RW, Vaziri N. Intestinal excretion of oxalate in chronic renal failure. J Am Soc Nephrol 5: 1339–1343, 1994.
27. Hatch M, Vaziri N. Enhanced enteric excretion of urate in rats with chronic renal failure. Clin Sci 86: 511–516, 1994. 29a.
28. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486: 207–214, 2012.
29. Jensen-Urstad AP, Semenkovich CF. Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger? Biochim Biophys Acta 1821: 747–753, 2012.
30. Jin UH, Lee SO, Sridharan G, Lee K, Davidson LA, Jayaraman A, Chapkin RS, Alaniz R, Safe S. Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities. Mol Pharmacol 85: 777–788, 2014.
31. Kalmokoff M, Zwicker B, O’Hara M, Matias F, Green J, Shastri P, Green-Johnson J, Brooks SP. Temporal change in the gut community of rats fed high amylose cornstarch is driven by endogenous urea rather than strictly on carbohydrate availability. J Appl Microbiol 114: 1516–1528, 2013.
32. Keenan MJ, Martin RJ, Raggio AM, McCutcheon KL, Brown IL, Birkett A, Newman SS, Skaf J, Hegsted M, Tulley RT, Blair E, Zhou J. A microarray study indicates high-amylose resistant starch increases hormones and improves structure and function of the GI tract. J Nutrigen Nutrigenomics 5: 26–44, 2012.
33. Komsta L. Package ‘outliers’ (online). https://cran.r-project.org/web/packages/outliers/outliers.pdf [17 August 2015].
34. Krishnamurthy VMR, Wei G, Baird BC, Murtaugh M, Chonchol MB, Raphael KL, Greene T, Beddhu S. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int 81: 300–306, 2012.
35. Leclercq S, Matamoros S, Cani PD, Neyrinck AM, Jamar F, Stärkel P, Windey K, Tremaroli V, Bäckhed F, Verbeke K, de Timary P, Delzenne NM. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci USA 111: E4485–E4493, 2014.
36. Lee SM, Han HW, Yim SY. Beneficial effects of soy milk and fiber on high cholesterol diet-induced alteration of gut microbiota and inflammatory gene expression in rats. Food Funct 6: 492–500, 2015.
37. Lennon G, Balfe A, Bambury N, Lavelle A, Maguire A, Docherty NG, Coffey JC, Winter DC, Sheahan K, O’Connell PR. Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis. Colorectal Dis 16: O161–O169, 2014.
38. Lewis HB. Studies in the synthesis of hippuric acid in the animal organism. II. The synthesis and rate of elimination of hippuric acid after benzoate ingestion in man. J Biol Chem 18: 225–231, 1914.
39. Li H, Ma ML, Luo S, Zhang RM, Han P, Hu W. Metabolic responses to ethanol in Saccharomyces cerevisiae using a gas chromatography tandem mass spectrometry-based metabolomics approach. Int J Biochem Cell Biol 44: 1087–1096, 2012.
40. Lin CJ, Chuang CK, Jayakumar T, Liu HL, Pan CF, Wang TJ, Chen HH, Wu CJ. Serum p-cresyl sulfate predicts cardiovascular disease and mortality in elderly hemodialysis patients. Arch Med Sci 9: 662–668, 2013.
41. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 71: 8228–8235, 2005.
42. Macfarlane GT, Allison C, Gibson SA, Cummings JH. Contribution of the microflora to proteolysis in the human large intestine. J Appl Bacteriol 64: 37–46, 1988.
43. Mardinoglu A, Shoaie S, Bergentall M, Ghaffari P, Zhang C, Larsson E, Backhed F, Nielsen J. The gut microbiota modulates host amino acid and glutathione metabolism in mice. Mol Syst Biol 11: 834, 2015.
44. Mevik B, Wehrens R, Liland KH. Package ‘pls’ (online). https://cran.rproject.org/web/packages/pls/pls.pdf [17 August 2015].
45. Morita T, Kasaoka S, Ohhashi A, Ikai M, Numasaki Y, Kiriyama S. Resistant proteins alter cecal short-chain fatty acid profiles in rats fed high amylose cornstarch. J Nutr 128: 1156–1164, 1998.
46. Nasir O, Umbach AT, Rexhepaj R, Ackermann TF, Bhandaru M, Ebrahim A, Artunc F, Kempe DS, Puchchakayala G, Siraskar B, Foller M, Saeed A, Lang F. Effects of gum arabic (Acacia senegal) on renal function in diabetic mice. Kidney Blood Press Res 35: 365–372, 2012.
47. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42: S1–S201, 2003.
48. Pettersen JE, Jellum E. The identification and metabolic origin of 2-furoylglycine and 2,5-furandicarboxylic acid in human urine. Clin Chim Acta 41: 199–207, 1972.
49. Phillips J, Muir JG, Birkett A, Lu ZX, Jones GP, O’Dea K, Young GP. Effect of resistant starch on fecal bulk and fermentation-dependent events in humans. Am J Clin Nutr 62: 121–130, 1995.
50. Pitcher MC, Cummings JH. Hydrogen sulphide: a bacterial toxin in ulcerative colitis? Gut 39: 1–4, 1996.
51. R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2014.
52. Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol 25: 657–670, 2014.
53. Rampton D, Cohen S, Crammond V, Gibbons J, Lilburn M, Rabet J, Vince A, Wager J, Wrong O. Treatment of chronic renal failure with dietary fiber. Clin Nephrol 21: 159–163, 1984.
54. Ravussin Y, Koren O, Spor A, LeDuc C, Gutman R, Stombaugh J, Knight R, Ley RE, Leibel RL. Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity (Silver Spring) 20: 738–747, 2012.
55. Robert P. Structural and functional adaptation in renal failure-II. Br Med J 1: 1372–1377, 1952.
56. Sanghavi S, Whiting S, Uribarri J. Potassium balance in dialysis patients. Semin Dial 26: 597–603, 2013.
57. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut 35: S35–S38, 1994.
58. Scholz M, Fiehn O. SetupX–a public study design database for metabolomic projects. Pac Sympos Biocomput 2007: 169–180, 2007.
59. Shaw W. Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia. Nutr Neurosci 13: 135–143, 2010.
60. Sirich TL, Plummer NS, Gardner CD, Hostetter TH, Meyer TW. Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients. Clin J Am Soc Nephrol 9: 1603–1610, 2014.
61. Smith EA, Macfarlane GT. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol 81: 288–302, 1996.
62. Smith EA, Macfarlane GT. Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine. Microbial Ecol 33: 180–188, 1997.
63. Sonnenburg ED, Sonnenburg JL. Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab 20: 779–786, 2014.
64. Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, Weatherford J, Buhler JD, Gordon JI. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307: 1955–1959, 2005.
65. Suchodolski JS, Markel ME, Garcia-Mazcorro JF, Unterer S, Heilmann RM, Dowd SE, Kachroo P, Ivanov I, Minamoto Y, Dillman EM, Steiner JM, Cook AK, Toresson L. The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease. PLos One 7: e51907, 2012.
66. Sun Y, O’Riordan MX. Regulation of bacterial pathogenesis by intestinal short-chain fatty acids. Adv Appl Microbiol 85: 93–118, 2013.
67. Tachon S, Zhou J, Keenan M, Martin R, Marco ML. The intestinal microbiota in aged mice is modulated by dietary resistant starch and correlated with improvements in host responses. FEMS Microbiol Ecol 83: 299–309, 2013.
68. Toyohara T, Akiyama Y, Suzuki T, Takeuchi Y, Mishima E, Tanemoto M, Momose A, Toki N, Sato H, Nakayama M, Hozawa A, Tsuji I, Ito S, Soga T, Abe T. Metabolomic profiling of uremic solutes in CKD patients. Hypertens Res 33: 944–952, 2010.
69. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027–1131, 2006.
70. Umu OC, Frank JA, Fangel JU, Oostindjer M, da Silva CS, Bolhuis EJ, Bosch G, Willats WG, Pope PB, Diep DB. Resistant starch diet induces change in the swine microbiome and a predominance of beneficial bacterial populations. Microbiome 3: 16, 2015.
71. Vandeputte D, Falony G, Vieira-Silva S, Tito RY, Joossens M, Raes J. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65: 57–62, 2016.
72. Vanholder R, De Smet R. Pathophysiologic effects of uremic retention solutes. J Am Soc Nephrol 10: 1815–1823, 1999.
73. Vanholder R, Schepers E, Pletinck A, Nagler EV, Glorieux G. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol 25: 1897–1907, 2014.
74. Vaziri ND, Liu SM, Lau WL, Khazaeli M, Nazertehrani S, Farzaneh SH, Kieffer DA, Adams SH, Martin RJ. High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease. PLos One 9: e114881, 2014.
75. Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH, Andersen GL. Chronic kidney disease alters intestinal microbial flora. Kidney Int 83: 308–315, 2013.
76. Vaziri ND, Yuan J, Norris K. Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in CKD. Am J Nephrol 37: 1–6, 2013.
77. Vaziri ND, Yuan J, Rahimi A, Ni Z, Said H, Subramanian VS. Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol Dial Transplant 27: 2686–2693, 2012.
78. Wang F, Jiang H, Shi K, Ren Y, Zhang P, Cheng S. Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients. Nephrology (Carlton) 17: 733–738, 2012.
79. Wang L, Christophersen C, Sorich M, Gerber J, Angley M, Conlon M. Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder. Mol Autism 4: 42, 2013.
80. Williams BL, Hornig M, Parekh T, Lipkin WI. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. mBio 3: 2012.
81. Williams RE, Eyton-Jones HW, Farnworth MJ, Gallagher R, Provan WM. Effect of intestinal microflora on the urinary metabolic profile of rats: a 1H-nuclear magnetic resonance spectroscopy study. Xenobiotica 32: 783–794, 2002.
82. Wold S, Sjöström M, Eriksson L. PLS-regression: a basic tool of chemometrics. Chemometrics Intelligent Lab Syst 58: 109–130, 2001.
83. Wong J, Piceno YM, Desantis TZ, Pahl M, Andersen GL, Vaziri ND. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol 39: 230–237, 2014.
84. Younes H, Alphonse JC, Behr SR, Demigné C, Rémésy C. Role of fermentable carbohydrate supplements with a low-protein diet in the course of chronic renal failure: experimental bases. Am J Kidney Dis 33: 633–646, 1999.
85. Younes H, Demigné C, Behr S, Rémésy C. Resistant starch exerts a lowering effect on plasma urea by enhancing urea N transfer into the large intestine. Nutr Res 15: 1199–1210, 1995.
86. Younes H, Egret N, Hadj-Abdelkader M, Rémésy C, Demigné C, Gueret C, Deteix P, Alphonse JC. Fermentable carbohydrate supplementation alters nitrogen excretion in chronic renal failure. J Renal Nutr 16: 67–74, 2006.
87. Ze X, Duncan SH, Louis P, Flint HJ. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J 6: 1535–1543, 2012.